Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Side effects and safety profiles Every effective metabolic peptide comes with trade-offs
WADA Prohibition The World Anti-Doping Agency classification for these peptides: GLP3 likely classified under prohibited substances as a GLP-1 receptor agonist Cagrilintide status as amylin analog may fall under peptide hormone prohibitions Combined formulation would be prohibited under multiple substance categories No Therapeutic Use Exemptions (TUEs) available for either component Detection methods under development for anti-doping testing WADAs position reflects that these remain investigational agents without regulatory approval from health authorities worldwide
Whether eventually starting cagrlintide and tirzepatide therapy or managing ongoing treatment, patients benefit from rapid, personalized responses to their health questions and convenient access to doctors
Avoiding these simple errors is more than half the battle
US$ 28.19
US$ 24.25
US$ 20.12
US$ 26.03
US$ 20.61
US$ 25.60
US$ 25.68